RxSight (RXST) Net Shares Issued and Repurchased (2020 - 2026)

RxSight (RXST) has reported Net Shares Issued and Repurchased for 7 consecutive years, with $1.6 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Net Shares Issued and Repurchased rose 33.34% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 33.34% YoY), and the FY2025 full-year result was $1.5 million, up 26.05% from the prior year.
• Net Shares Issued and Repurchased improved to $1.6 million in Q1 2026 per RXST's latest filing, from $1.5 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $1.6 million in Q1 2026 and bottomed at $531640.0 in Q1 2022.
• Historically, Net Shares Issued and Repurchased has averaged $1.2 million across 5 years, with a median of $1.2 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Net Shares Issued and Repurchased tumbled 44.14% in 2022, then soared 138.19% in 2023.
• Over 5 years, Net Shares Issued and Repurchased stood at $1.1 million in 2022, then rose by 27.54% to $1.5 million in 2023, then declined by 18.14% to $1.2 million in 2024, then grew by 26.05% to $1.5 million in 2025, then grew by 8.48% to $1.6 million in 2026.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $1.6 million, $1.5 million, and $1.2 million for Q1 2026, Q4 2025, and Q1 2025 respectively.